"Ther Adv Vaccines Immunother"[Journal] - Search Results

Year	Number of Results
2017	2
2018	6
2019	11
2020	16
2021	14
2022	17
2023	18
2024	27
2025	21
2026	4

1

Effectiveness and feasibility of vaccination interventions for Indigenous and hard-to-reach populations in Latin America and the Caribbean: a systematic review and meta-analysis.

Husaini DC, Morales S, Hung JC, Eck L. Husaini DC, et al. Ther Adv Vaccines Immunother. 2026 Aug 3;14:25151355261472591. doi: 10.1177/25151355261472591. eCollection 2026. Ther Adv Vaccines Immunother. 2026. PMID: 42553363 Free PMC article. Review.

2

Innovations in HPV vaccination and their role in global cervical cancer control: a review.

H Chuwa A. H Chuwa A. Ther Adv Vaccines Immunother. 2026 Jun 29;14:25151355261449446. doi: 10.1177/25151355261449446. eCollection 2026. Ther Adv Vaccines Immunother. 2026. PMID: 42389684 Free PMC article. Review.

3

Exploring supplemental immunization strategies to reach zero-dose children in low- and middle-income countries: a scoping review.

Carcelen AC, Sauer M, Sangha P, Manandhar P, Kostandova N, Kong AC, Larson R, Limaye RJ, Moss WJ. Carcelen AC, et al. Ther Adv Vaccines Immunother. 2026 Apr 27;14:25151355261442364. doi: 10.1177/25151355261442364. eCollection 2026. Ther Adv Vaccines Immunother. 2026. PMID: 42079367 Free PMC article.

4

Rabies post-exposure prophylaxis in India: a SWOT analysis.

Pardeshi G, Sharma P, Ittiel A. Pardeshi G, et al. Ther Adv Vaccines Immunother. 2026 Jan 2;14:25151355251410780. doi: 10.1177/25151355251410780. eCollection 2026. Ther Adv Vaccines Immunother. 2026. PMID: 41487407 Free PMC article. Review.

5

Exploring the safety and immunogenicity of the VLA15 vaccine among healthy or high-risk population: a systematic review and meta-analysis of randomized controlled trials.

Abbasi TN, Khan MS, Siddiqui E, Zaheer MA, Tabassum A, Zainab N, Waafira A. Abbasi TN, et al. Ther Adv Vaccines Immunother. 2025 Oct 28;13:25151355251387927. doi: 10.1177/25151355251387927. eCollection 2025. Ther Adv Vaccines Immunother. 2025. PMID: 41179932 Free PMC article. Review.

6

Immunization safety monitoring: addressing vaccine hesitancy and enhancing coverage in crisis-affected regions-insights from Lebanon, Ukraine, and Sudan.

Nasr R, Swaidan E, Hachem S, Yazbek N, Rizk M, Abdel Rahman A, H Alami N. Nasr R, et al. Ther Adv Vaccines Immunother. 2025 Sep 25;13:25151355251380220. doi: 10.1177/25151355251380220. eCollection 2025. Ther Adv Vaccines Immunother. 2025. PMID: 41018819 Free PMC article. Review.

7

The urgent need for a licensed dengue vaccine in the Philippines.

Cordero DA Jr. Cordero DA Jr. Ther Adv Vaccines Immunother. 2025 Sep 23;13:25151355251380216. doi: 10.1177/25151355251380216. eCollection 2025. Ther Adv Vaccines Immunother. 2025. PMID: 41001211 Free PMC article. No abstract available.

8

Uptake of human papillomavirus vaccination and associated factors among high school female students in Dessie City Administration, North East Ethiopia: a cross-sectional study.

Hussen A, Tadesse N, Andargie EM, Adem YF. Hussen A, et al. Ther Adv Vaccines Immunother. 2025 Sep 17;13:25151355251375970. doi: 10.1177/25151355251375970. eCollection 2025. Ther Adv Vaccines Immunother. 2025. PMID: 40979685 Free PMC article.

9

Bridging the gaps in Mpox vaccine equity: insights and imperatives from the Philippine public health landscape.

Rogayan DV Jr. Rogayan DV Jr. Ther Adv Vaccines Immunother. 2025 Aug 17;13:25151355251369156. doi: 10.1177/25151355251369156. eCollection 2025. Ther Adv Vaccines Immunother. 2025. PMID: 40832459 Free PMC article. No abstract available.

10

Cervical cancer trends, HPV vaccine utilization, and screening in low- and lower-middle-income countries: an updated review.

Hamid MKI, Hasneen S, Lima AK, Shawon SR, Shahriar M, Anjum R. Hamid MKI, et al. Ther Adv Vaccines Immunother. 2025 Jul 24;13:25151355251356646. doi: 10.1177/25151355251356646. eCollection 2025. Ther Adv Vaccines Immunother. 2025. PMID: 40718465 Free PMC article. Review.

11

Mpox vaccine in the Philippines: the waiting continues, but until when?

Cordero DA Jr. Cordero DA Jr. Ther Adv Vaccines Immunother. 2025 Jul 6;13:25151355251356647. doi: 10.1177/25151355251356647. eCollection 2025. Ther Adv Vaccines Immunother. 2025. PMID: 40626095 Free PMC article. No abstract available.

12

Trends in uptake and impact of thermostable vaccines in Africa.

Kitui SK, Juma E, Ndalama MT, Chilot D, Tolossa D, Woldemedhin B, Muzazu SGY, Digamo K, Mungania J, Manyazewal T. Kitui SK, et al. Ther Adv Vaccines Immunother. 2025 Jun 18;13:25151355251341662. doi: 10.1177/25151355251341662. eCollection 2025. Ther Adv Vaccines Immunother. 2025. PMID: 40538680 Free PMC article. Review.

13

Evaluating the immunogenicity and safety of ID93 + GLA-SE in BCG-vaccinated healthy adults: a systematic review and meta-analysis of randomized controlled trials.

Siddiqui E, Khan MS, Khalid M, Chandani HK, Naeem U, Khan MM, Wasti SO. Siddiqui E, et al. Ther Adv Vaccines Immunother. 2025 Jun 5;13:25151355251344473. doi: 10.1177/25151355251344473. eCollection 2025. Ther Adv Vaccines Immunother. 2025. PMID: 40485775 Free PMC article. Review.

14

Human Papillomavirus (HPV) vaccination practices and associated factors among female adolescent students in Eastern Zone of Tigray, Northern Ethiopia, 2024.

Teka TB, Legese H, Shishay T, Mengesha MB, Gebremedhin H. Teka TB, et al. Ther Adv Vaccines Immunother. 2025 May 24;13:25151355251340205. doi: 10.1177/25151355251340205. eCollection 2025. Ther Adv Vaccines Immunother. 2025. PMID: 40415764 Free PMC article.

15

Parents' hesitance to vaccinate their daughters with the human papillomavirus vaccine and its associated factors in Northwest Ethiopia.

Belachew TW, Mekuriaw BY, Ferede WY, Tegegne DM, Mengistu TD, Tadesse SG, Tariku YD, Sisay FA, Mitiku AK. Belachew TW, et al. Ther Adv Vaccines Immunother. 2025 May 8;13:25151355251337622. doi: 10.1177/25151355251337622. eCollection 2025. Ther Adv Vaccines Immunother. 2025. PMID: 40351827 Free PMC article.

16

Norovirus outbreaks and the necessity of a future NoV vaccine.

Cordero DA Jr. Cordero DA Jr. Ther Adv Vaccines Immunother. 2025 Apr 21;13:25151355251335511. doi: 10.1177/25151355251335511. eCollection 2025. Ther Adv Vaccines Immunother. 2025. PMID: 40291642 Free PMC article. No abstract available.

17

Improving the human papillomavirus vaccination in the Philippines.

Cordero DA Jr. Cordero DA Jr. Ther Adv Vaccines Immunother. 2025 Mar 17;13:25151355251326783. doi: 10.1177/25151355251326783. eCollection 2025. Ther Adv Vaccines Immunother. 2025. PMID: 40104155 Free PMC article. No abstract available.

18

Parental hesitancy for pediatric COVID-19 vaccines in Chile.

Cedillo D, Godoy MJ, Leal P, Villena R. Cedillo D, et al. Ther Adv Vaccines Immunother. 2025 Mar 12;13:25151355251322312. doi: 10.1177/25151355251322312. eCollection 2025. Ther Adv Vaccines Immunother. 2025. PMID: 40078505 Free PMC article.

19

Serious adverse events following immunization and predictors of mortality associated with COVID-19 vaccination in India: a secondary data analysis of nationwide causality assessments.

Rajan AK, Bashar MA. Rajan AK, et al. Ther Adv Vaccines Immunother. 2025 Mar 2;13:25151355251321697. doi: 10.1177/25151355251321697. eCollection 2025. Ther Adv Vaccines Immunother. 2025. PMID: 40034661 Free PMC article.

20

Perceived benefits, information, vaccination history, and conspiracy beliefs as significant determinants of RSV vaccine acceptance among Arab seniors.

Sallam M, Al-Mahzoum K, Yousef ZM, Alfouzan JS, Alharbi MJ, Alsubaiei MK, Albalwah MYM, Shehadeh MW, Obeidat RJ, Yaseen KO, Abdelaziz DH, Salim NA, Sallam M, Barakat M. Sallam M, et al. Ther Adv Vaccines Immunother. 2025 Feb 27;13:25151355251324384. doi: 10.1177/25151355251324384. eCollection 2025. Ther Adv Vaccines Immunother. 2025. PMID: 40027198 Free PMC article.

21

Pembrolizumab-induced myasthenia gravis with isolated diaphragmatic involvement in a lung cancer patient: a case report.

Mouratidou N, Papadopoulos D, Vrouvaki I, Skouras V, Katsenos S. Mouratidou N, et al. Ther Adv Vaccines Immunother. 2025 Feb 27;13:25151355251324374. doi: 10.1177/25151355251324374. eCollection 2025. Ther Adv Vaccines Immunother. 2025. PMID: 40017810 Free PMC article.

22

Recommendations for dengue vaccine implementation in the elderly population.

Giang NNT, Taylor-Robinson AW. Giang NNT, et al. Ther Adv Vaccines Immunother. 2025 Feb 17;13:25151355251321718. doi: 10.1177/25151355251321718. eCollection 2025. Ther Adv Vaccines Immunother. 2025. PMID: 39963378 Free PMC article. Review.

23

Current advances and challenges in mpox vaccine development: a global landscape.

Shafaati M, Forghani S, Shahsavand Davoudi A, Samiee R, Mohammadi K, Akbarpour S, Seifi A, Salehi M, Zare M. Shafaati M, et al. Ther Adv Vaccines Immunother. 2025 Jan 27;13:25151355251314339. doi: 10.1177/25151355251314339. eCollection 2025. Ther Adv Vaccines Immunother. 2025. PMID: 39872308 Free PMC article. Review.

24

Knowledge, attitude, practices, and associated factors toward cervical cancer among female health sciences students of Addis Ababa University, Addis Ababa, Ethiopia.

Endale S, Delelegn K, Negash Z. Endale S, et al. Ther Adv Vaccines Immunother. 2025 Jan 27;13:25151355251314733. doi: 10.1177/25151355251314733. eCollection 2025. Ther Adv Vaccines Immunother. 2025. PMID: 39872307 Free PMC article.

25

The recent landscape of RSV vaccine research.

Kelleher K, Subramaniam N, Drysdale SB. Kelleher K, et al. Ther Adv Vaccines Immunother. 2025 Jan 10;13:25151355241310601. doi: 10.1177/25151355241310601. eCollection 2025. Ther Adv Vaccines Immunother. 2025. PMID: 39802673 Free PMC article. Review.

26

Association between cannabis use and clinical outcomes in patients with solid malignancies receiving immune checkpoint inhibitors.

Hadid T, Biedny A, Mamdani H, Azmi A, Kim S, Jang H, Uprety D, Al Hallak MN, Sukari A. Hadid T, et al. Ther Adv Vaccines Immunother. 2024 Dec 25;12:25151355241309095. doi: 10.1177/25151355241309095. eCollection 2024. Ther Adv Vaccines Immunother. 2024. PMID: 39737331 Free PMC article.

27

Acceptability of human papillomavirus vaccination in the United Kingdom: a systematic review of the literature on uptake of, and barriers and facilitators to HPV vaccination.

Karakusevic A, Foss AM. Karakusevic A, et al. Ther Adv Vaccines Immunother. 2024 Dec 25;12:25151355241308313. doi: 10.1177/25151355241308313. eCollection 2024. Ther Adv Vaccines Immunother. 2024. PMID: 39737330 Free PMC article. Review.

28

From setbacks to success: lessons from the journey of RSV vaccine development.

Cnossen VM, van Leeuwen RP, Mazur NI, Vernhes C, Ten Voorde W, Burggraaf J, de Visser SJ, Roestenberg M, Kamerling IMC. Cnossen VM, et al. Ther Adv Vaccines Immunother. 2024 Dec 19;12:25151355241308305. doi: 10.1177/25151355241308305. eCollection 2024. Ther Adv Vaccines Immunother. 2024. PMID: 39711948 Free PMC article. Review.

29

Artificial intelligence for chimeric antigen receptor-based therapies: a comprehensive review of current applications and future perspectives.

Shahzadi M, Rafique H, Waheed A, Naz H, Waheed A, Zokirova FR, Khan H. Shahzadi M, et al. Ther Adv Vaccines Immunother. 2024 Dec 16;12:25151355241305856. doi: 10.1177/25151355241305856. eCollection 2024. Ther Adv Vaccines Immunother. 2024. PMID: 39691280 Free PMC article. Review.

30

Factors associated with tetanus toxoid vaccine utilization among reproductive-age women in Debre Markos town, Ethiopia, 2021: a cross-sectional study.

Tamiru YD, Sendo EG, Deressa JT. Tamiru YD, et al. Ther Adv Vaccines Immunother. 2024 Dec 13;12:25151355241305855. doi: 10.1177/25151355241305855. eCollection 2024. Ther Adv Vaccines Immunother. 2024. PMID: 39678101 Free PMC article.

31

Timeliness and coverage of childhood vaccination in the Philippines: evaluating delays and disparities in immunization uptake.

G Corpuz JC. G Corpuz JC. Ther Adv Vaccines Immunother. 2024 Dec 7;12:25151355241305848. doi: 10.1177/25151355241305848. eCollection 2024. Ther Adv Vaccines Immunother. 2024. PMID: 39651039 Free PMC article. No abstract available.

32

Insight into pharmacy students' perspectives on mandatory COVID-19 vaccines in schools and healthcare settings.

Ahmed F, Ottallah S, Siddiqui A, Smith C, Borghol A. Ahmed F, et al. Ther Adv Vaccines Immunother. 2024 Dec 7;12:25151355241303628. doi: 10.1177/25151355241303628. eCollection 2024. Ther Adv Vaccines Immunother. 2024. PMID: 39651038 Free PMC article.

33

Enhancing Tdap vaccine uptake: key insights for Filipino maternal health.

Toledo JPC. Toledo JPC. Ther Adv Vaccines Immunother. 2024 Nov 30;12:25151355241303631. doi: 10.1177/25151355241303631. eCollection 2024. Ther Adv Vaccines Immunother. 2024. PMID: 39619211 Free PMC article. No abstract available.

34

Pediatric asthma and COVID-19 vaccination: unveiling patterns of hesitancy and acceptance.

Tavakol M, Gharagozlou S, Abbasi M, Zamani Z, Gharagozlou M. Tavakol M, et al. Ther Adv Vaccines Immunother. 2024 Nov 13;12:25151355241297874. doi: 10.1177/25151355241297874. eCollection 2024. Ther Adv Vaccines Immunother. 2024. PMID: 39544988 Free PMC article.

35

Mapping changes in the utilization of childhood immunization over 5 years in a south Indian tertiary care hospital.

Mathew M, Sanathan SR, Sebastian J, Ravi MD, Joy T, Theempalangad RM, Gowda P. Mathew M, et al. Ther Adv Vaccines Immunother. 2024 Oct 29;12:25151355241287705. doi: 10.1177/25151355241287705. eCollection 2024. Ther Adv Vaccines Immunother. 2024. PMID: 39493461 Free PMC article.

36

COVID-19 vaccination in children aged 5-11: a systematic review of parental barriers and facilitators in Western countries.

Davey SA, Gaffiero D. Davey SA, et al. Ther Adv Vaccines Immunother. 2024 Oct 11;12:25151355241288115. doi: 10.1177/25151355241288115. eCollection 2024. Ther Adv Vaccines Immunother. 2024. PMID: 39421135 Free PMC article. Review.

37

Predictors of Tdap vaccine acceptance in pregnancy before and after delivery.

Toubiyan D, Fogel J, Jacobs AJ. Toubiyan D, et al. Ther Adv Vaccines Immunother. 2024 Oct 11;12:25151355241287689. doi: 10.1177/25151355241287689. eCollection 2024. Ther Adv Vaccines Immunother. 2024. PMID: 39403252 Free PMC article.

38

Vaccine skepticism and vaccine development stages; inoculation from "cowpox" lesion to the current mRNA vaccine of COVID-19: review.

Tafere C, Demsie DG, Tefera BB, Yehualaw A, Feyisa K, Yismaw MB, Yayehrad AT. Tafere C, et al. Ther Adv Vaccines Immunother. 2024 Oct 11;12:25151355241288135. doi: 10.1177/25151355241288135. eCollection 2024. Ther Adv Vaccines Immunother. 2024. PMID: 39399302 Free PMC article. Review.

39

Multiple myeloma and the potential of new checkpoint inhibitors for immunotherapy.

Kamali AN, Hamedifar H, Eisenhut M, Bautista JM. Kamali AN, et al. Ther Adv Vaccines Immunother. 2024 Oct 9;12:25151355241288453. doi: 10.1177/25151355241288453. eCollection 2024. Ther Adv Vaccines Immunother. 2024. PMID: 39399301 Free PMC article. Review.

40

Exploring COVID-19 vaccine adverse events among pregnant women: a cross-sectional study, 2022.

Amer AA, Amer SA, Badokhon A, Hammad SM, Wasfy MA, Khan M, Ateyah Al-Harbi T, Alobaid SQ, Eskander G, Abdel-Azeem A, Alshowair A, Ramadan MS. Amer AA, et al. Ther Adv Vaccines Immunother. 2024 Oct 5;12:25151355241285594. doi: 10.1177/25151355241285594. eCollection 2024. Ther Adv Vaccines Immunother. 2024. PMID: 39376246 Free PMC article.

41

COVID-19 vaccine coverage effectiveness among elderly with geographical information system mapping: what about Indonesia?

Wulan WR, Widianawati E, Wahyuni AT. Wulan WR, et al. Ther Adv Vaccines Immunother. 2024 Sep 27;12:25151355241285379. doi: 10.1177/25151355241285379. eCollection 2024. Ther Adv Vaccines Immunother. 2024. PMID: 39372968 Free PMC article.

42

Relative effectiveness of COVID-19 vaccine booster doses in people aged 65 and older-a retrospective cohort study in Türkiye.

Sezerol MA, Sarisaltik A. Sezerol MA, et al. Ther Adv Vaccines Immunother. 2024 Sep 27;12:25151355241285375. doi: 10.1177/25151355241285375. eCollection 2024. Ther Adv Vaccines Immunother. 2024. PMID: 39372967 Free PMC article.

43

Knowledge, attitude, and acceptance of COVID-19 vaccine in pregnant women.

Kuptarak A, Phupong V. Kuptarak A, et al. Ther Adv Vaccines Immunother. 2024 Sep 21;12:25151355241278832. doi: 10.1177/25151355241278832. eCollection 2024. Ther Adv Vaccines Immunother. 2024. PMID: 39345730 Free PMC article.

44

Comparative 60-day effectiveness of bivalent versus monovalent mRNA vaccines in Shelby County: a population-level analysis.

Plaxco AP, Kmet J, Smeltzer MP, Jiang Y, Taylor M, Nolan VG. Plaxco AP, et al. Ther Adv Vaccines Immunother. 2024 Sep 19;12:25151355241278852. doi: 10.1177/25151355241278852. eCollection 2024. Ther Adv Vaccines Immunother. 2024. PMID: 39314902 Free PMC article.

45

Vaccination practices and knowledge among adults with hemoglobinopathies in Greece: a nationwide survey.

Delicou S, Manganas K, Xydaki A, Evliati L, Myrilla I, Rubatis L, Kostaridou S. Delicou S, et al. Ther Adv Vaccines Immunother. 2024 Sep 17;12:25151355241278869. doi: 10.1177/25151355241278869. eCollection 2024. Ther Adv Vaccines Immunother. 2024. PMID: 39314901 Free PMC article.

46

Media literacy: exploring the key to social media influences for wise parental decision-making on vaccines.

Cordero DA Jr. Cordero DA Jr. Ther Adv Vaccines Immunother. 2024 Sep 12;12:25151355241277780. doi: 10.1177/25151355241277780. eCollection 2024. Ther Adv Vaccines Immunother. 2024. PMID: 39282687 Free PMC article. No abstract available.

47

Monoclonal IgY antibodies: advancements and limitations for immunodiagnosis and immunotherapy applications.

Tabll AA, Shahein YE, Omran MM, Hussein NA, El-Shershaby A, Petrovic A, Glasnovic M, Smolic R, Smolic M. Tabll AA, et al. Ther Adv Vaccines Immunother. 2024 Jul 25;12:25151355241264520. doi: 10.1177/25151355241264520. eCollection 2024. Ther Adv Vaccines Immunother. 2024. PMID: 39071998 Free PMC article. Review.

48

Routine immunization for children in the Philippines: challenges and interventions.

Cordero DA Jr. Cordero DA Jr. Ther Adv Vaccines Immunother. 2024 Jun 24;12:25151355241264528. doi: 10.1177/25151355241264528. eCollection 2024. Ther Adv Vaccines Immunother. 2024. PMID: 39044998 Free PMC article. No abstract available.

49

Developing and validating a scale to measure the perceptions of safety, usability and acceptability of microarray patches for vaccination: a study protocol.

Berger MN, Davies C, Mathieu E, Shaban RZ, Bag S, Skinner SR. Berger MN, et al. Ther Adv Vaccines Immunother. 2024 Jun 24;12:25151355241263560. doi: 10.1177/25151355241263560. eCollection 2024. Ther Adv Vaccines Immunother. 2024. PMID: 39044997 Free PMC article.

50

Exploring social media influences on vaccine decision-making in parents: a netnography.

Smith SE, Sivertsen N, Lines L, De Bellis A. Smith SE, et al. Ther Adv Vaccines Immunother. 2024 May 8;12:25151355241249607. doi: 10.1177/25151355241249607. eCollection 2024. Ther Adv Vaccines Immunother. 2024. PMID: 38726045 Free PMC article.

51

Adjuvants in COVID-19 vaccines: innocent bystanders or culpable abettors for stirring up COVID-heart syndrome.

Kanuri SH, Sirrkay PJ. Kanuri SH, et al. Ther Adv Vaccines Immunother. 2024 Feb 4;12:25151355241228439. doi: 10.1177/25151355241228439. eCollection 2024. Ther Adv Vaccines Immunother. 2024. PMID: 38322819 Free PMC article. Review.

52

Lessons learned from a cluster of immunization errors in newborns.

Alj L, Tebaa A, Talibi I, Moubarik S, Benazzouz M, Soulaymani Bencheikh R. Alj L, et al. Ther Adv Vaccines Immunother. 2024 Jan 2;12:25151355231221009. doi: 10.1177/25151355231221009. eCollection 2024. Ther Adv Vaccines Immunother. 2024. PMID: 38178960 Free PMC article.

53

Addressing disparities in funding for robust cancer research.

Cordero DA Jr. Cordero DA Jr. Ther Adv Vaccines Immunother. 2023 Dec 15;11:25151355231219083. doi: 10.1177/25151355231219083. eCollection 2023. Ther Adv Vaccines Immunother. 2023. PMID: 38107389 Free PMC article. No abstract available.

54

Stagnation or safety? Reassessment of the human papillomavirus vaccination dosing regimen in Japan.

Namba M, Kaneda Y, Iida M. Namba M, et al. Ther Adv Vaccines Immunother. 2023 Dec 11;11:25151355231216408. doi: 10.1177/25151355231216408. eCollection 2023. Ther Adv Vaccines Immunother. 2023. PMID: 38090642 Free PMC article. No abstract available.

55

Efficacy of oral mefenamic acid versus paracetamol as a prophylactic analgesic for needle pain in children receiving vaccination: a three-arm, parallel, triple-blind, placebo-controlled MAP VaC randomized controlled trial.

Pasi R, Babu TA, Kallidoss VK. Pasi R, et al. Ther Adv Vaccines Immunother. 2023 Dec 6;11:25151355231216122. doi: 10.1177/25151355231216122. eCollection 2023. Ther Adv Vaccines Immunother. 2023. PMID: 38077267 Free PMC article.

56

Flu vaccination in the Philippines: challenges and interventions.

Cordero DA Jr. Cordero DA Jr. Ther Adv Vaccines Immunother. 2023 Nov 17;11:25151355231213587. doi: 10.1177/25151355231213587. eCollection 2023. Ther Adv Vaccines Immunother. 2023. PMID: 38020960 Free PMC article. No abstract available.

57

Designing an inclusive immunization schedule for children and adults in India.

Niazi F, Nidhi Kaur K, Saeed S, Shannawaz M. Niazi F, et al. Ther Adv Vaccines Immunother. 2023 Nov 17;11:25151355231213573. doi: 10.1177/25151355231213573. eCollection 2023. Ther Adv Vaccines Immunother. 2023. PMID: 38020959 Free PMC article. No abstract available.

58

COVID-19 vaccine immune response and plasma cell dyscrasia.

Kleebayoon A, Wiwanitkit V. Kleebayoon A, et al. Ther Adv Vaccines Immunother. 2023 Nov 9;11:25151355231209733. doi: 10.1177/25151355231209733. eCollection 2023. Ther Adv Vaccines Immunother. 2023. PMID: 37954638 Free PMC article. No abstract available.

59

Cancer vaccine strategies for the treatment of diffusely infiltrating gliomas.

Jucht A, Dumont S, Pooley C, Gonzalez Castro LN. Jucht A, et al. Ther Adv Vaccines Immunother. 2023 Oct 24;11:25151355231206163. doi: 10.1177/25151355231206163. eCollection 2023. Ther Adv Vaccines Immunother. 2023. PMID: 37886714 Free PMC article. Review.

60

Significant improvement of systemic lupus erythematosus manifestation in children after autologous dendritic cell transfer: a case report and review of literature.

Jonny, Putranto TA, Purnama Y, Djatmiko R, Yana ML, Sitepu EC, Irfon R. Jonny, et al. Ther Adv Vaccines Immunother. 2023 Sep 13;11:25151355231186005. doi: 10.1177/25151355231186005. eCollection 2023. Ther Adv Vaccines Immunother. 2023. PMID: 37719802 Free PMC article.

61

Immune checkpoints and cancer immunotherapies: insights into newly potential receptors and ligands.

Kamali AN, Bautista JM, Eisenhut M, Hamedifar H. Kamali AN, et al. Ther Adv Vaccines Immunother. 2023 Aug 30;11:25151355231192043. doi: 10.1177/25151355231192043. eCollection 2023. Ther Adv Vaccines Immunother. 2023. PMID: 37662491 Free PMC article. Review.

62

COVID-19 vaccine immune response in patients with plasma cell dyscrasia: a systematic review.

Faizan U, Nair LG, Bou Zerdan M, Jaberi-Douraki M, Anwer F, Raza S. Faizan U, et al. Ther Adv Vaccines Immunother. 2023 Aug 27;11:25151355231190497. doi: 10.1177/25151355231190497. eCollection 2023. Ther Adv Vaccines Immunother. 2023. PMID: 37645011 Free PMC article. Review.

63

Active surveillance of adverse events following COVID-19 vaccines in a tertiary care hospital.

Cherian NM, Durai DA, Jaisel M, Sharma D, Sebastian J, Basavaraja CK, Mathew M. Cherian NM, et al. Ther Adv Vaccines Immunother. 2023 Aug 26;11:25151355231193975. doi: 10.1177/25151355231193975. eCollection 2023. Ther Adv Vaccines Immunother. 2023. PMID: 37641637 Free PMC article.

64

COVID-19 vaccine acceptance and its determinants among residents of Ambo Town, West Shewa, Oromia Region, Ethiopia: cross-sectional survey.

Beressa TB, Tafa M, Geresu GD, Bacha AJ, Gadisa DA. Beressa TB, et al. Ther Adv Vaccines Immunother. 2023 Jun 24;11:25151355231178150. doi: 10.1177/25151355231178150. eCollection 2023. Ther Adv Vaccines Immunother. 2023. PMID: 37377465 Free PMC article.

65

Clinico-epidemiological profile and outcome of infected health care workers during the three consecutive waves of COVID-19 pandemic: a longitudinal cohort study.

Mathew M, Sebastian J, Doddaiah N, Thomas A, Narayanappa S. Mathew M, et al. Ther Adv Vaccines Immunother. 2023 Jun 21;11:25151355231181744. doi: 10.1177/25151355231181744. eCollection 2023. Ther Adv Vaccines Immunother. 2023. PMID: 37362156 Free PMC article.

66

COVID-19 after rituximab therapy in cSLE patients.

Nelson MC, Manos CK, Flanagan E, Prahalad S. Nelson MC, et al. Ther Adv Vaccines Immunother. 2023 Jun 21;11:25151355231181242. doi: 10.1177/25151355231181242. eCollection 2023. Ther Adv Vaccines Immunother. 2023. PMID: 37362155 Free PMC article.

67

Leveraging identity and access management technology to accelerate emergency COVID-19 vaccine delivery.

Gellert GA. Gellert GA. Ther Adv Vaccines Immunother. 2023 May 29;11:25151355231173830. doi: 10.1177/25151355231173830. eCollection 2023. Ther Adv Vaccines Immunother. 2023. PMID: 37261278 Free PMC article.

68

Immunogenicity and safety of vaccination in children with paediatric rheumatic diseases: a scoping review.

Cunninghame J, Wen S, Dufficy M, Ullman A, Takashima M, Cann M, Doyle R. Cunninghame J, et al. Ther Adv Vaccines Immunother. 2023 Apr 25;11:25151355231167116. doi: 10.1177/25151355231167116. eCollection 2023. Ther Adv Vaccines Immunother. 2023. PMID: 37124959 Free PMC article.

69

Socioeconomic and demographic characteristics influencing the hesitancy and refusal of COVID-19 vaccine in Ghana.

Sampene AK, Li C, Oteng Agyeman F, Brenya R. Sampene AK, et al. Ther Adv Vaccines Immunother. 2023 Feb 9;11:25151355221149336. doi: 10.1177/25151355221149336. eCollection 2023. Ther Adv Vaccines Immunother. 2023. PMID: 36778098 Free PMC article.

70

Decision-making in childhood vaccination: vaccine hesitancy among caregivers of under-5 children from a tertiary care institution in Eastern India.

Sahoo SS, Parida SP, Singh AK, Palepu S, Sahoo DP, Bhatia V. Sahoo SS, et al. Ther Adv Vaccines Immunother. 2023 Feb 3;11:25151355231152650. doi: 10.1177/25151355231152650. eCollection 2023. Ther Adv Vaccines Immunother. 2023. PMID: 36756042 Free PMC article.

71

Different drug approaches to COVID-19 treatment worldwide: an update of new drugs and drugs repositioning to fight against the novel coronavirus.

Oliver JC, Silva EN, Soares LM, Scodeler GC, Santos AS, Corsetti PP, Prudêncio CR, de Almeida LA. Oliver JC, et al. Ther Adv Vaccines Immunother. 2022 Dec 23;10:25151355221144845. doi: 10.1177/25151355221144845. eCollection 2022. Ther Adv Vaccines Immunother. 2022. PMID: 36578829 Free PMC article. Review.

72

Influenza vaccination coverage rates and other related factors in high-risk groups in Birjand, East of Iran.

Ebrahimzadeh A, Bijari B, Azarnoosh A, Shakhs Emampour F. Ebrahimzadeh A, et al. Ther Adv Vaccines Immunother. 2022 Nov 26;10:25151355221140229. doi: 10.1177/25151355221140229. eCollection 2022. Ther Adv Vaccines Immunother. 2022. PMID: 36452217 Free PMC article.

73

Third wave COVID-19 delta variant breakthrough infection in a Hispanic-dominant suburb of Miami, Florida: ethical dilemma and vaccination hesitancy.

Kara S, Lazovic G, Chohan F, Lawrence JA, Sukaina M, Edaki O, Nedd K. Kara S, et al. Ther Adv Vaccines Immunother. 2022 Oct 8;10:25151355221128086. doi: 10.1177/25151355221128086. eCollection 2022. Ther Adv Vaccines Immunother. 2022. PMID: 36225944 Free PMC article.

74

Lymphadenopathy subsequent to Covishield (ChAdOx1 nCoV-19) Corona virus vaccine: ultrasound findings and clinical implications.

Sahoo SS, Kaur N, Kaur A, Garg S. Sahoo SS, et al. Ther Adv Vaccines Immunother. 2022 Sep 17;10:25151355221124018. doi: 10.1177/25151355221124018. eCollection 2022. Ther Adv Vaccines Immunother. 2022. PMID: 36133302 Free PMC article.

75

T cells in SARS-CoV-2 infection and vaccination.

Young A. Young A. Ther Adv Vaccines Immunother. 2022 Aug 24;10:25151355221115011. doi: 10.1177/25151355221115011. eCollection 2022. Ther Adv Vaccines Immunother. 2022. PMID: 36051003 Free PMC article. Review.

76

Improving health literacy with mumps, measles and rubella (MMR) vaccination: comparison of the readability of MMR patient-facing literature and MMR scientific abstracts.

Downey T, Millar BC, Moore JE. Downey T, et al. Ther Adv Vaccines Immunother. 2022 Aug 22;10:25151355221118812. doi: 10.1177/25151355221118812. eCollection 2022. Ther Adv Vaccines Immunother. 2022. PMID: 36035444 Free PMC article.

77

Clinical profile of ChAdOx1 nCoV-19- and BBV152-vaccinated individuals among hospitalized COVID-19 patients: a pair-matched study.

Keri VC, Arunan B, Kodan P, Soneja M, Nischal N, Varadarajan A, Didwania A, R L B, Aggarwal A, Jorwal P, Kumar A, Ray A, Sethi P, Meena VP, Khanna P, Singh AK, Aggarwal R, Soni KD, Goyal A, Das A, Trikha A, Wig N. Keri VC, et al. Ther Adv Vaccines Immunother. 2022 Aug 9;10:25151355221115009. doi: 10.1177/25151355221115009. eCollection 2022. Ther Adv Vaccines Immunother. 2022. PMID: 35966176 Free PMC article.

78

Measles-rubella vaccine-associated MOG-antibody positive acute demyelinating encephalomyelitis with optic neuritis in a child.

Otiv M, Botre A, Shah P. Otiv M, et al. Ther Adv Vaccines Immunother. 2022 Aug 9;10:25151355221115016. doi: 10.1177/25151355221115016. eCollection 2022. Ther Adv Vaccines Immunother. 2022. PMID: 35966175 Free PMC article.

79

Vaccine apartheid: the separation of the world's poorest and most vulnerable and the birth of Omicron.

Prasad S, Shahid A, Co ELF, Khatri G, Cheema HA, Rocha ICN, Bardhan M, Hasan MM. Prasad S, et al. Ther Adv Vaccines Immunother. 2022 Jul 5;10:25151355221107975. doi: 10.1177/25151355221107975. eCollection 2022. Ther Adv Vaccines Immunother. 2022. PMID: 35832726 Free PMC article. No abstract available.

80

The involvement of microRNAs in HCV and HIV infection.

Joshi N, Chandane Tak M, Mukherjee A. Joshi N, et al. Ther Adv Vaccines Immunother. 2022 Jul 5;10:25151355221106104. doi: 10.1177/25151355221106104. eCollection 2022. Ther Adv Vaccines Immunother. 2022. PMID: 35832725 Free PMC article. Review.

81

Current advancements and future prospects of COVID-19 vaccines and therapeutics: a narrative review.

Sanyaolu A, Okorie C, Marinkovic A, Prakash S, Williams M, Haider N, Mangat J, Hosein Z, Balendra V, Abbasi AF, Desai P, Jain I, Utulor S, Abioye A. Sanyaolu A, et al. Ther Adv Vaccines Immunother. 2022 May 30;10:25151355221097559. doi: 10.1177/25151355221097559. eCollection 2022. Ther Adv Vaccines Immunother. 2022. PMID: 35664358 Free PMC article. Review.

82

Predicting epitopes for vaccine development using bioinformatics tools.

Yurina V, Adianingsih OR. Yurina V, et al. Ther Adv Vaccines Immunother. 2022 May 21;10:25151355221100218. doi: 10.1177/25151355221100218. eCollection 2022. Ther Adv Vaccines Immunother. 2022. PMID: 35647486 Free PMC article. Review.

83

Monitoring the safety of influenza A/H1N1 pandemic and seasonal vaccines in Morocco.

Tebaa A, Benkirane R, Alj L, Cherkaoui I, Soulaymani-Bencheikh R. Tebaa A, et al. Ther Adv Vaccines Immunother. 2022 Mar 29;10:25151355221088157. doi: 10.1177/25151355221088157. eCollection 2022. Ther Adv Vaccines Immunother. 2022. PMID: 35372783 Free PMC article.

84

Low rate of COVID-19 vaccination in Africa: a cause for concern.

Al-Kassim Hassan M, Adam Bala A, Jatau AI. Al-Kassim Hassan M, et al. Ther Adv Vaccines Immunother. 2022 Mar 24;10:25151355221088159. doi: 10.1177/25151355221088159. eCollection 2022. Ther Adv Vaccines Immunother. 2022. PMID: 35355936 Free PMC article. No abstract available.

85

Global herpes zoster incidence, burden of disease, and vaccine availability: a narrative review.

Pan CX, Lee MS, Nambudiri VE. Pan CX, et al. Ther Adv Vaccines Immunother. 2022 Mar 21;10:25151355221084535. doi: 10.1177/25151355221084535. eCollection 2022. Ther Adv Vaccines Immunother. 2022. PMID: 35340552 Free PMC article. Review.

86

Identifying higher risk subgroups of health care workers for priority vaccination against COVID-19.

Haq M, Rehman A, Haq M, Haq H, Rajab H, Ahmad J, Ahmed J, Anwar S, Ahmad S, Haq NU. Haq M, et al. Ther Adv Vaccines Immunother. 2022 Mar 10;10:25151355221080724. doi: 10.1177/25151355221080724. eCollection 2022. Ther Adv Vaccines Immunother. 2022. PMID: 35295994 Free PMC article.

87

COVID-19 vaccine hesitancy: Pakistan struggles to vaccinate its way out of the pandemic.

Mehmood Q, Ullah I, Hasan MM, Kazmi SK, Ahmadi A, Lucero-Prisno DE 3rd. Mehmood Q, et al. Ther Adv Vaccines Immunother. 2022 Feb 10;10:25151355221077658. doi: 10.1177/25151355221077658. eCollection 2022. Ther Adv Vaccines Immunother. 2022. PMID: 35174312 Free PMC article. No abstract available.

88

Safety and reactogenicity of the adjuvanted recombinant zoster vaccine: experience from clinical trials and post-marketing surveillance.

Fiore J, Co-van der Mee MM, Maldonado A, Glasser L, Watson P. Fiore J, et al. Ther Adv Vaccines Immunother. 2021 Nov 30;9:25151355211057479. doi: 10.1177/25151355211057479. eCollection 2021. Ther Adv Vaccines Immunother. 2021. PMID: 35005428 Free PMC article. Review.

89

Comprehensive literature review on COVID-19 vaccines and role of SARS-CoV-2 variants in the pandemic.

Yap C, Ali A, Prabhakar A, Prabhakar A, Pal A, Lim YY, Kakodkar P. Yap C, et al. Ther Adv Vaccines Immunother. 2021 Nov 24;9:25151355211059791. doi: 10.1177/25151355211059791. eCollection 2021. Ther Adv Vaccines Immunother. 2021. PMID: 34870090 Free PMC article. Review.

90

Adverse events following COVID-19 vaccination: first 90 days of experience from a tertiary care teaching hospital in South India.

Basavaraja CK, Sebastian J, Ravi MD, John SB. Basavaraja CK, et al. Ther Adv Vaccines Immunother. 2021 Nov 22;9:25151355211055833. doi: 10.1177/25151355211055833. eCollection 2021. Ther Adv Vaccines Immunother. 2021. PMID: 34841193 Free PMC article.

91

Anaphylaxis after Moderna COVID-19 vaccine.

Mayfield J, Bandi S, Ganti L, Rubero J. Mayfield J, et al. Ther Adv Vaccines Immunother. 2021 Oct 28;9:25151355211048418. doi: 10.1177/25151355211048418. eCollection 2021. Ther Adv Vaccines Immunother. 2021. PMID: 34734159 Free PMC article.

92

Improving vaccine-related health literacy in parents: comparison on the readability of CDC Vaccine Information Statements (VIS) and Health and Human Services (HHS) patient-facing vaccine literature.

Millar BC, Moore JE. Millar BC, et al. Ther Adv Vaccines Immunother. 2021 Sep 29;9:25151355211047521. doi: 10.1177/25151355211047521. eCollection 2021. Ther Adv Vaccines Immunother. 2021. PMID: 34604697 Free PMC article. No abstract available.

93

Vaccine hesitancy in Africa: causes and strategies to the rescue.

Aborode AT, Fajemisin EA, Ekwebelem OC, Tsagkaris C, Taiwo EA, Uwishema O, Awoniyi OO, Ahmad S, Essar MY, Adanur I, Yunusa I. Aborode AT, et al. Ther Adv Vaccines Immunother. 2021 Sep 28;9:25151355211047514. doi: 10.1177/25151355211047514. eCollection 2021. Ther Adv Vaccines Immunother. 2021. PMID: 34604696 Free PMC article. No abstract available.

94

Transdermal approaches to vaccinations in the COVID-19 pandemic era.

Lee MS, Pan CX, Nambudiri VE. Lee MS, et al. Ther Adv Vaccines Immunother. 2021 Aug 21;9:25151355211039073. doi: 10.1177/25151355211039073. eCollection 2021. Ther Adv Vaccines Immunother. 2021. PMID: 34447901 Free PMC article. Review.

95

Impact of educational intervention on the best immunization practices among practicing health care professionals in a south Indian city.

Sebastian J, Parthasarathi G, Ravi MD. Sebastian J, et al. Ther Adv Vaccines Immunother. 2021 Jul 31;9:25151355211032590. doi: 10.1177/25151355211032590. eCollection 2021. Ther Adv Vaccines Immunother. 2021. PMID: 34377928 Free PMC article.

96

Pregnant women's hepatitis B vaccination coverage in Nigeria: a national pilot cross-sectional study.

Eleje GU, Akaba GO, Mbachu II, Rabiu A, Loto OM, Usman HA, Fiebai PO, Chukwuanukwu RC, Joe-Ikechebelu NN, Nwankwo CH, Kalu SO, Onubogu CU, Ogbuagu CN, Chukwurah SN, Uzochukwu CE, Inuyomi SO, Adesoji BA, Ogwaluonye UC, Nweje SI, Egeonu RO, Igue OE, Jibuaku CH, Aja PO, Chidozie CP, Ibrahim HS, Aliyu FE, Numan AI, Okoro OD, Omoruyi SA, Oppah IC, Anyang UI, Ahmed A, Umeononihu OS, Umeh EO, Emeka EA, Onwuegbuna AA, Igbodike EP, Ajuba IC, Yakasai IA, Ezechi OC, Ikechebelu JI; Triplex Infection in Pregnancy Collaboration Group. Eleje GU, et al. Ther Adv Vaccines Immunother. 2021 Jul 29;9:25151355211032595. doi: 10.1177/25151355211032595. eCollection 2021. Ther Adv Vaccines Immunother. 2021. PMID: 34377929 Free PMC article.

97

Generating CAR T cells from tumor-infiltrating lymphocytes.

Mills JK, Henderson MA, Giuffrida L, Petrone P, Westwood JA, Darcy PK, Neeson PJ, Kershaw MH, Gyorki DE. Mills JK, et al. Ther Adv Vaccines Immunother. 2021 May 31;9:25151355211017119. doi: 10.1177/25151355211017119. eCollection 2021. Ther Adv Vaccines Immunother. 2021. PMID: 34159293 Free PMC article.

98

Is it time to administer acellular pertussis vaccine to childbearing age/pregnant women in all areas using whole-cell pertussis vaccination schedule?

Esteghamati A, Sayyahfar S, Alimohamadi Y, Salahi S, Faramarzi M. Esteghamati A, et al. Ther Adv Vaccines Immunother. 2021 May 25;9:25151355211015842. doi: 10.1177/25151355211015842. eCollection 2021. Ther Adv Vaccines Immunother. 2021. PMID: 34104864 Free PMC article.

99

Dengvaxia: the world's first vaccine for prevention of secondary dengue.

Tully D, Griffiths CL. Tully D, et al. Ther Adv Vaccines Immunother. 2021 May 17;9:25151355211015839. doi: 10.1177/25151355211015839. eCollection 2021. Ther Adv Vaccines Immunother. 2021. PMID: 34036241 Free PMC article. Review.

100

Impact of indirect education on knowledge and perception on cervical cancer and its prevention among the parents of adolescent girls: an interventional school-based study.

Jacob RA, Abraham PS, Thomas FR, Navya V, Sebastian J, Ravi MD, Gurumurthy P. Jacob RA, et al. Ther Adv Vaccines Immunother. 2021 Feb 11;9:2515135521990268. doi: 10.1177/2515135521990268. eCollection 2021. Ther Adv Vaccines Immunother. 2021. PMID: 33629029 Free PMC article.

101

Strategies for active and passive pediatric RSV immunization.

Eichinger KM, Kosanovich JL, Lipp M, Empey KM, Petrovsky N. Eichinger KM, et al. Ther Adv Vaccines Immunother. 2021 Feb 10;9:2515135520981516. doi: 10.1177/2515135520981516. eCollection 2021. Ther Adv Vaccines Immunother. 2021. PMID: 33623860 Free PMC article. Review.

102

The digital immunization system of the future: imagining a patient-centric, interoperable immunization information system.

Atkinson KM, Mithani SS, Bell C, Rubens-Augustson T, Wilson K. Atkinson KM, et al. Ther Adv Vaccines Immunother. 2020 Oct 28;8:2515135520967203. doi: 10.1177/2515135520967203. eCollection 2020. Ther Adv Vaccines Immunother. 2020. PMID: 33681700 Free PMC article. Review.

103

Optimising immunisation in children with 22q11 microdeletion.

Berkhout A, Preece K, Varghese V, Prasad V, Heussler H, Clark J, Wen SCH. Berkhout A, et al. Ther Adv Vaccines Immunother. 2020 Oct 16;8:2515135520957139. doi: 10.1177/2515135520957139. eCollection 2020. Ther Adv Vaccines Immunother. 2020. PMID: 33150298 Free PMC article.

104

Efficiently cleaved HIV-1 envelopes: can they be important for vaccine immunogen development?

Das S, Kumar R, Ahmed S, Parray HA, Samal S. Das S, et al. Ther Adv Vaccines Immunother. 2020 Oct 8;8:2515135520957763. doi: 10.1177/2515135520957763. eCollection 2020. Ther Adv Vaccines Immunother. 2020. PMID: 33103053 Free PMC article. Review.

105

Evaluation of two commercially-available Salmonella vaccines on Salmonella in the peripheral lymph nodes of experimentally-infected cattle.

Edrington TS, Arthur TM, Loneragan GH, Genovese KJ, Hanson DL, Anderson RC, Nisbet DJ. Edrington TS, et al. Ther Adv Vaccines Immunother. 2020 Oct 5;8:2515135520957760. doi: 10.1177/2515135520957760. eCollection 2020. Ther Adv Vaccines Immunother. 2020. PMID: 33089062 Free PMC article.

106

Delivery of adoptive cell therapy in the context of the health-care system in the UK: challenges for clinical sites.

Pillai M, Davies MM, Thistlethwaite FC. Pillai M, et al. Ther Adv Vaccines Immunother. 2020 Sep 20;8:2515135520944355. doi: 10.1177/2515135520944355. eCollection 2020. Ther Adv Vaccines Immunother. 2020. PMID: 33015538 Free PMC article. Review.

107

Evaluation of immunogenicity, safety and breakthrough following administration of live attenuated varicella vaccine in two doses three months apart regimen in Indian children.

Mitra M, Chowdhury J, Basu S, Halder PP, Mukherjee M, Karadkhele A, Puppalwar G, Jain R. Mitra M, et al. Ther Adv Vaccines Immunother. 2020 Aug 11;8:2515135520937216. doi: 10.1177/2515135520937216. eCollection 2020. Ther Adv Vaccines Immunother. 2020. PMID: 32851202 Free PMC article.

108

COVID-19: should oral vaccination strategies be given more consideration?

Mehan A, Venkatesh A, Girish M. Mehan A, et al. Ther Adv Vaccines Immunother. 2020 Jul 27;8:2515135520946503. doi: 10.1177/2515135520946503. eCollection 2020. Ther Adv Vaccines Immunother. 2020. PMID: 32778854 Free PMC article. No abstract available.

109

Profile of adverse events following immunization with measles rubella vaccine at a tertiary care hospital in East Delhi, India.

Bhowmik E, Singh A, Sachan R. Bhowmik E, et al. Ther Adv Vaccines Immunother. 2020 Jul 7;8:2515135520940131. doi: 10.1177/2515135520940131. eCollection 2020. Ther Adv Vaccines Immunother. 2020. PMID: 32685913 Free PMC article.

110

Development of vaccines against the sexually transmitted infections gonorrhoea, syphilis, Chlamydia, herpes simplex virus, human immunodeficiency virus and Zika virus.

McIntosh EDG. McIntosh EDG. Ther Adv Vaccines Immunother. 2020 Jun 27;8:2515135520923887. doi: 10.1177/2515135520923887. eCollection 2020. Ther Adv Vaccines Immunother. 2020. PMID: 32647779 Free PMC article. Review.

111

Transgenic T-cell receptor immunotherapy for cancer: building on clinical success.

Oppermans N, Kueberuwa G, Hawkins RE, Bridgeman JS. Oppermans N, et al. Ther Adv Vaccines Immunother. 2020 Jun 22;8:2515135520933509. doi: 10.1177/2515135520933509. eCollection 2020. Ther Adv Vaccines Immunother. 2020. PMID: 32613155 Free PMC article. Review.

112

CAR T-cell immunotherapy of B-cell malignancy: the story so far.

Halim L, Maher J. Halim L, et al. Ther Adv Vaccines Immunother. 2020 May 27;8:2515135520927164. doi: 10.1177/2515135520927164. eCollection 2020. Ther Adv Vaccines Immunother. 2020. PMID: 32524070 Free PMC article. Review.

113

Safety and immunogenicity of a seasonal trivalent inactivated split influenza vaccine: a double blind, phase III randomized clinical trial in healthy Serbian adults.

Stevanovic G, Obradovic A, Ristic S, Petrovic D, Milenkovic B, Mitrovic D, Vignjevic SF, Ilic K, Stoiljkovic V, Lavadinovic L, Pelemis M, Petrovic S, Vidmanic A, Popovic O, Eremic N, Sparrow E, Torelli G, Socquet M, Holt R, Ilieva-Borisova Y, Tang Y, Scorza FB, Flores J, Rathi N. Stevanovic G, et al. Ther Adv Vaccines Immunother. 2020 May 25;8:2515135520925336. doi: 10.1177/2515135520925336. eCollection 2020. Ther Adv Vaccines Immunother. 2020. PMID: 32518891 Free PMC article.

114

Neisseria meningitidis: analysis of pili and LPS in emerging Brazilian strains.

Portilho AI, Trzewikoswki de Lima G, De Gaspari E. Portilho AI, et al. Ther Adv Vaccines Immunother. 2020 May 8;8:2515135520919195. doi: 10.1177/2515135520919195. eCollection 2020. Ther Adv Vaccines Immunother. 2020. PMID: 32435751 Free PMC article.

115

Checkpoint inhibitor blockade and epigenetic reprogrammability in CD8⁺ T-cell activation and exhaustion.

Belizário J, Destro Rodrigues MF. Belizário J, et al. Ther Adv Vaccines Immunother. 2020 Mar 13;8:2515135520904238. doi: 10.1177/2515135520904238. eCollection 2020. Ther Adv Vaccines Immunother. 2020. PMID: 32206744 Free PMC article. Review.

116

Influenza vaccines: the potential benefits of cell-culture isolation and manufacturing.

Rajaram S, Boikos C, Gelone DK, Gandhi A. Rajaram S, et al. Ther Adv Vaccines Immunother. 2020 Feb 22;8:2515135520908121. doi: 10.1177/2515135520908121. eCollection 2020. Ther Adv Vaccines Immunother. 2020. PMID: 32128506 Free PMC article. Review.

117

Hepatitis B vaccine knowledge and self-reported vaccination status among healthcare workers in a conflict region in northeastern Nigeria.

Dayyab FM, Iliyasu G, Ahmad BG, Bako AT, Ngamariju SS, Habib AG. Dayyab FM, et al. Ther Adv Vaccines Immunother. 2020 Jan 16;8:2515135519900743. doi: 10.1177/2515135519900743. eCollection 2020. Ther Adv Vaccines Immunother. 2020. PMID: 32002499 Free PMC article.

118

Cross-reactivity with Brazilian strains of Neisseria meningitidis B after immunization with outer membrane vesicles.

Trzewikoswki de Lima G, Portilho AI, De Gaspari E. Trzewikoswki de Lima G, et al. Ther Adv Vaccines Immunother. 2019 Dec 11;7:2515135519894825. doi: 10.1177/2515135519894825. eCollection 2019. Ther Adv Vaccines Immunother. 2019. PMID: 31853514 Free PMC article.

119

Active surveillance of adverse events following immunization (AEFI): a prospective 3-year vaccine safety study.

Sebastian J, Gurumurthy P, Ravi MD, Ramesh M. Sebastian J, et al. Ther Adv Vaccines Immunother. 2019 Nov 21;7:2515135519889000. doi: 10.1177/2515135519889000. eCollection 2019. Ther Adv Vaccines Immunother. 2019. PMID: 31799496 Free PMC article.

120

Insights into innate and adaptive immune responses in vaccine development against EV-A71.

Lim HX, Poh CL. Lim HX, et al. Ther Adv Vaccines Immunother. 2019 Nov 21;7:2515135519888998. doi: 10.1177/2515135519888998. eCollection 2019. Ther Adv Vaccines Immunother. 2019. PMID: 31799495 Free PMC article. Review.

121

Is a universal influenza vaccine feasible?

Phillipson JE, Babecoff R, Ben-Yedidia T. Phillipson JE, et al. Ther Adv Vaccines Immunother. 2019 Nov 7;7:2515135519885547. doi: 10.1177/2515135519885547. eCollection 2019. Ther Adv Vaccines Immunother. 2019. PMID: 35174313 Free PMC article.

122

Alphavirus-based hepatitis C virus therapeutic vaccines: can universal helper epitopes enhance HCV-specific cytotoxic T lymphocyte responses?

Koutsoumpli G, Ip PP, Schepel I, Hoogeboom BN, Boerma A, Daemen T. Koutsoumpli G, et al. Ther Adv Vaccines Immunother. 2019 Oct 3;7:2515135519874677. doi: 10.1177/2515135519874677. eCollection 2019. Ther Adv Vaccines Immunother. 2019. PMID: 31620673 Free PMC article.

123

Seasonal influenza vaccination: knowledge, attitude and practice in Varna, Bulgaria.

Ermenlieva NM, Tsankova GS, Todorova TT. Ermenlieva NM, et al. Ther Adv Vaccines Immunother. 2019 Sep 25;7:2515135519868152. doi: 10.1177/2515135519868152. eCollection 2019. Ther Adv Vaccines Immunother. 2019. PMID: 31598582 Free PMC article.

124

Identification of goals and barriers to treatment from 92 consecutive consultations with families considering peanut oral immunotherapy.

Blackman AC, Anagnostou A. Blackman AC, et al. Ther Adv Vaccines Immunother. 2019 Aug 26;7:2515135519869763. doi: 10.1177/2515135519869763. eCollection 2019. Ther Adv Vaccines Immunother. 2019. PMID: 31489399 Free PMC article.

125

Therapeutic vaccination immunomodulation: forming the basis of all cancer immunotherapy.

Coventry BJ. Coventry BJ. Ther Adv Vaccines Immunother. 2019 Aug 1;7:2515135519862234. doi: 10.1177/2515135519862234. eCollection 2019. Ther Adv Vaccines Immunother. 2019. PMID: 31414074 Free PMC article. Review.

126

A review of H5Nx avian influenza viruses.

Nuñez IA, Ross TM. Nuñez IA, et al. Ther Adv Vaccines Immunother. 2019 Feb 22;7:2515135518821625. doi: 10.1177/2515135518821625. eCollection 2019. Ther Adv Vaccines Immunother. 2019. PMID: 30834359 Free PMC article. Review.

127

Burden, effectiveness and safety of influenza vaccines in elderly, paediatric and pregnant populations.

Sullivan SG, Price OH, Regan AK. Sullivan SG, et al. Ther Adv Vaccines Immunother. 2019 Feb 7;7:2515135519826481. doi: 10.1177/2515135519826481. eCollection 2019. Ther Adv Vaccines Immunother. 2019. PMID: 30793097 Free PMC article. Review.

128

Cancer stem cell mobilization and therapeutic targeting of the 5T4 oncofetal antigen.

Harrop R, O'Neill E, Stern PL. Harrop R, et al. Ther Adv Vaccines Immunother. 2019 Jan 25;7:2515135518821623. doi: 10.1177/2515135518821623. eCollection 2019. Ther Adv Vaccines Immunother. 2019. PMID: 30719508 Free PMC article. Review.

129

The failure of radical treatments to cure cancer: can less deliver more?

Dalgleish AG, Stern PL. Dalgleish AG, et al. Ther Adv Vaccines Immunother. 2018 Dec 20;6(5-6):69-76. doi: 10.1177/2515135518815393. eCollection 2018 Sep. Ther Adv Vaccines Immunother. 2018. PMID: 30623172 Free PMC article. Review.

130

Broadly neutralizing antibodies in HIV-1 treatment and prevention.

Kumar R, Qureshi H, Deshpande S, Bhattacharya J. Kumar R, et al. Ther Adv Vaccines Immunother. 2018 Oct 12;6(4):61-68. doi: 10.1177/2515135518800689. eCollection 2018 Aug. Ther Adv Vaccines Immunother. 2018. PMID: 30345419 Free PMC article. Review.

131

Optimal use of meningococcal serogroup B vaccines: moving beyond outbreak control.

Balmer P, York LJ. Balmer P, et al. Ther Adv Vaccines Immunother. 2018 Jun 21;6(3):49-60. doi: 10.1177/2515135518781757. eCollection 2018 May. Ther Adv Vaccines Immunother. 2018. PMID: 30182092 Free PMC article. Review.

132

Novel tumour antigens and the development of optimal vaccine design.

Brentville VA, Atabani S, Cook K, Durrant LG. Brentville VA, et al. Ther Adv Vaccines Immunother. 2018 Apr;6(2):31-47. doi: 10.1177/2515135518768769. Epub 2018 Apr 10. Ther Adv Vaccines Immunother. 2018. PMID: 29998219 Free PMC article. Review.

133

Healthcare-associated infections: potential for prevention through vaccination.

McIntosh EDG. McIntosh EDG. Ther Adv Vaccines Immunother. 2018 Feb;6(1):19-27. doi: 10.1177/2515135518763183. Epub 2018 Mar 14. Ther Adv Vaccines Immunother. 2018. PMID: 29998218 Free PMC article. Review.

134

Bispecific antibodies in cancer immunotherapy.

Dahlén E, Veitonmäki N, Norlén P. Dahlén E, et al. Ther Adv Vaccines Immunother. 2018 Feb;6(1):3-17. doi: 10.1177/2515135518763280. Epub 2018 Mar 28. Ther Adv Vaccines Immunother. 2018. PMID: 29998217 Free PMC article. Review.

135

The influence of radiation in the context of developing combination immunotherapies in cancer.

Honeychurch J, Illidge TM. Honeychurch J, et al. Ther Adv Vaccines Immunother. 2017 Dec;5(6):115-122. doi: 10.1177/2051013617750561. Epub 2018 Jan 24. Ther Adv Vaccines Immunother. 2017. PMID: 29998216 Free PMC article. Review.

136

It is time to accelerate building local vaccine adjuvant manufacturing capacity.

Fox CB. Fox CB. Ther Adv Vaccines Immunother. 2017 Dec;5(6):111-113. doi: 10.1177/2051013617733259. Epub 2017 Oct 9. Ther Adv Vaccines Immunother. 2017. PMID: 29998215 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

136 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

136 results

Results by year